A Cell-free Expression Pipeline for the Generation and Functional Characterization of Nanobodies.
Ontology highlight
ABSTRACT: Cell-free systems are well-established platforms for the rapid synthesis, screening, engineering and modification of all kinds of recombinant proteins ranging from membrane proteins to soluble proteins, enzymes and even toxins. Also within the antibody field the cell-free technology has gained considerable attention with respect to the clinical research pipeline including antibody discovery and production. Besides the classical full-length monoclonal antibodies (mAbs), so-called "nanobodies" (Nbs) have come into focus. A Nb is the smallest naturally-derived functional antibody fragment known and represents the variable domain (VHH, ∼15 kDa) of a camelid heavy-chain-only antibody (HCAb). Based on their nanoscale and their special structure, Nbs display striking advantages concern
SUBMITTER: Haueis L
PROVIDER: S-EPMC9096027 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature
ACCESS DATA